Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients - A clinical trial to registry data comparison

Beelen, Dietrich Wilhelm; Iacobelli, Simona; Koster, Linda; Eikema, Dirk-Jan; van Biezen, Anja; Stoelzel, Friedrich; Ciceri, Fabio; Bethge, Wolfgang; Dreger, Peter; Wagner-Drouet, Eva-Maria; Remenyi, Peter; Stelljes, Matthias; Markiewicz, Miroslaw; Mclornan, Donal P.; Yakoub-Agha, Ibrahim; Mohty, Mohamad

Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients - A clinical trial to registry data comparison

Autor(en):

Beelen, Dietrich Wilhelm; Iacobelli, Simona; Koster, Linda; Eikema, Dirk-Jan; van Biezen, Anja; Stoelzel, Friedrich; Ciceri, Fabio; Bethge, Wolfgang; Dreger, Peter; Wagner-Drouet, Eva-Maria; Remenyi, Peter; Stelljes, Matthias; Markiewicz, Miroslaw; Mclornan, Donal P.; Yakoub-Agha, Ibrahim; Mohty, Mohamad

Tübinger Autor(en):

Bethge, Wolfgang Andreas

Erschienen in:

Bone Marrow Transplantation (2024), Bd. 59, H. 5, S. 670-679

Verlagsangabe:

London : Springernature

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1038/s41409-024-02241-2

ISSN:

0268-3369